From the BP report summary --
. COVID-19 has impacted recruitment in Phase 2 DEP-trials,
however sites have reinitiated
recruitment (London sites a bit slower than regional UK sites) and at this
stage results from all the trials are expected within the next 6-7 months,
which would serve as significant re-rating catalysts for the stock.
I would suggest this info has come from SPL HQ
Bell Potter raises target to $2.20, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
